TrialInternational journal of clinical practice2023

Efficacy of Nanocurcumin as an Add-On Treatment for Patients Hospitalized with COVID-19: A Double-Blind, Randomized Clinical Trial.

Sedigheh Ahmadi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.